Patents by Inventor Miho Tanaka
Miho Tanaka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220332842Abstract: In order to provide an antibody having high therapeutic and prophylactic effects against cancer and the like, three types of mouse monoclonal antibodies were prepared which exhibit high affinities for a human-derived Eva1 protein. Moreover, constant regions of these antibodies were substituted with human-derived constant regions to also prepare chimeric antibodies. Further, these mouse antibodies and chimeric antibodies were found to have high ADCC and/or CDC activities. Furthermore, it was also revealed that administering these antibodies to mice having been subjected to melanoma cell administration suppresses the metastasis and the like of the cells to the lungs.Type: ApplicationFiled: April 25, 2022Publication date: October 20, 2022Applicant: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITYInventors: Toshitada TAKEMORI, Mikako Shirouzu, Miho Tanaka, Tamami Ueshima, Toru Kondo
-
Patent number: 11339224Abstract: In order to provide an antibody having high therapeutic and prophylactic effects against cancer and the like, three types of mouse monoclonal antibodies were prepared which exhibit high affinities for a human-derived Eva1 protein. Moreover, constant regions of these antibodies were substituted with human-derived constant regions to also prepare chimeric antibodies. Further, these mouse antibodies and chimeric antibodies were found to have high ADCC and/or CDC activities. Furthermore, it was also revealed that administering these antibodies to mice having been subjected to melanoma cell administration suppresses the metastasis and the like of the cells to the lungs.Type: GrantFiled: July 29, 2016Date of Patent: May 24, 2022Assignee: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITYInventors: Toshitada Takemori, Mikako Shirouzu, Miho Tanaka, Tamami Ueshima, Toru Kondo
-
Patent number: 10644988Abstract: A communication path management apparatus includes a memory, and a processor coupled to the memory and to decide, for each of processing-pairs, part of inter-adjacent-server communication paths that couple adjacent servers on communication paths among servers in the network as data-transfer-paths used for data transfer from a first processing to a second processing of a processing-pair, the processing-pair including first and second processings that are consecutive in the order of execution, based on an execution track record of the first processing that is earlier in the order of execution and the second processing that is later in the order of execution in the processing-pair in each of the servers, and instruct servers at both ends of the data-transfer-paths decided regarding each of the processing-pairs to carry out data transfer of an execution result of the first processing by the data-transfer-paths.Type: GrantFiled: May 31, 2018Date of Patent: May 5, 2020Assignee: FUJITSU LIMITEDInventors: Miho Tanaka, Hitoshi Ueno
-
Patent number: 10470026Abstract: A data transfer method includes: executing a process that stores sensor information including duplicate degrees and position information, the duplicate degrees indicating an amount of computers as transmission sources of inhibit signals received by the first computer; executing a process that transmits the inhibit signal including the duplicate degree in the sensor information to a computer that is present in a position to which direct communication via the short-distance radio communication is possible; executing a process that stores the duplicate degree in the inhibit signal, associates the duplicate degree with the transmission source of the inhibit signal, and increases the duplicate degree in the sensor information; and executing a process that transmits the position information in the sensor information to the management device in a case where the duplicate degree in the sensor information is higher than the duplicate degree associated with the transmission source of the inhibit signal.Type: GrantFiled: June 9, 2017Date of Patent: November 5, 2019Assignee: FUJITSU LIMITEDInventors: Miho Tanaka, Masataka Sonoda, Shunsuke Kikuchi, Noriyuki Fukuyama, Hitoshi Ueno
-
Publication number: 20190256610Abstract: In order to provide an antibody having high therapeutic and prophylactic effects against cancer and the like, three types of mouse monoclonal antibodies were prepared which exhibit high affinities for a human-derived Eva1 protein. Moreover, constant regions of these antibodies were substituted with human-derived constant regions to also prepare chimeric antibodies. Further, these mouse antibodies and chimeric antibodies were found to have high ADCC and/or CDC activities. Furthermore, it was also revealed that administering these antibodies to mice having been subjected to melanoma cell administration suppresses the metastasis and the like of the cells to the lungs.Type: ApplicationFiled: July 29, 2016Publication date: August 22, 2019Applicant: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITYInventors: Toshitada TAKEMORI, Mikako SHIROUZU, Miho TANAKA, Tamami UESHIMA, Toru KONDO
-
Publication number: 20180351849Abstract: A communication path management apparatus includes a memory, and a processor coupled to the memory and to decide, for each of processing-pairs, part of inter-adjacent-server communication paths that couple adjacent servers on communication paths among servers in the network as data-transfer-paths used for data transfer from a first processing to a second processing of a processing-pair, the processing-pair including first and second processings that are consecutive in the order of execution, based on an execution track record of the first processing that is earlier in the order of execution and the second processing that is later in the order of execution in the processing-pair in each of the servers, and instruct servers at both ends of the data-transfer-paths decided regarding each of the processing-pairs to carry out data transfer of an execution result of the first processing by the data-transfer-paths.Type: ApplicationFiled: May 31, 2018Publication date: December 6, 2018Applicant: FUJITSU LIMITEDInventors: MIHO TANAKA, Hitoshi UENO
-
Publication number: 20180007530Abstract: A data transfer method includes: executing a process that stores sensor information including duplicate degrees and position information, the duplicate degrees indicating an amount of computers as transmission sources of inhibit signals received by the first computer; executing a process that transmits the inhibit signal including the duplicate degree in the sensor information to a computer that is present in a position to which direct communication via the short-distance radio communication is possible; executing a process that stores the duplicate degree in the inhibit signal, associates the duplicate degree with the transmission source of the inhibit signal, and increases the duplicate degree in the sensor information; and executing a process that transmits the position information in the sensor information to the management device in a case where the duplicate degree in the sensor information is higher than the duplicate degree associated with the transmission source of the inhibit signal.Type: ApplicationFiled: June 9, 2017Publication date: January 4, 2018Applicant: FUJITSU LIMITEDInventors: MIHO TANAKA, Masataka Sonoda, Shunsuke KIKUCHI, Noriyuki FUKUYAMA, Hitoshi UENO
-
Patent number: 8694453Abstract: A dialogue control system that uses an ontology that systematically expresses domain knowledge representing concepts and relationships between concepts to determine questions for a user and implements the questions, and implements a dialogue in accordance with received user answers. One or more dimension-classified ontologies and a basic ontology are stored, a concept from a user response is specified as a condition, and one or a plural number of the dimension-classified ontologies that meet the specified condition are fetched. The content of the fetched dimension-classified ontology/ies is overwritten on the basic ontology, in order according to dimension priorities from the dimension-classified ontology with the lowest dimension priority, and a multidimensional ontology is generated. The dialogue control system uses this multidimensional ontology to control the dialogue.Type: GrantFiled: December 15, 2009Date of Patent: April 8, 2014Assignee: Oki Electric Industry Co., Ltd.Inventors: Mihoko Kitamura, Toshiki Murata, Tatsuya Sukehiro, Sayori Shimohata, Ikuo Orihara, Atsushi Ikeno, Shigehiro Kato, Miho Tanaka
-
Publication number: 20110282913Abstract: A dialogue control system that uses an ontology that systematically expresses domain knowledge representing concepts and relationships between concepts to determine questions for a user and implements the questions, and implements a dialogue in accordance with received user answers. One or more dimension-classified ontologies and a basic ontology are stored, a concept from a user response is specified as a condition, and one or a plural number of the dimension-classified ontologies that meet the specified condition are fetched. The content of the fetched dimension-classified ontology/ies is overwritten on the basic ontology, in order according to dimension priorities from the dimension-classified ontology with the lowest dimension priority, and a multidimensional ontology is generated. The dialogue control system uses this multidimensional ontology to control the dialogue.Type: ApplicationFiled: December 15, 2009Publication date: November 17, 2011Applicant: OKI ELECTRIC INDUSTRY CO., LTD.Inventors: Mihoko Kitamura, Toshiki Murata, Tatsuya Sukehiro, Sayori Shimohata, Ikuo Orihara, Atsushi Ikeno, Shigehiro Kato, Miho Tanaka
-
Publication number: 20110143199Abstract: A nonaqueous electrolyte secondary battery includes: a positive electrode 4 including a positive electrode current collector and a positive electrode material mixture layer containing a positive electrode active material and a binder and provided on the positive electrode current collector; a negative electrode 5; a porous insulating layer 6 interposed between the positive electrode 4 and the negative electrode 5; and a nonaqueous electrolyte. The positive electrode 4 has a tensile extension percentage of 3.0% or more. The binder is made of polyvinylidene fluoride. The positive electrode current collector has a softening temperature lower than a crystalline melting point of the binder.Type: ApplicationFiled: July 14, 2009Publication date: June 16, 2011Inventors: Yoshiyuki Muraoka, Yasushi Hirakawa, Miho Tanaka
-
Publication number: 20110136010Abstract: A nonaqueous electrolyte secondary battery includes: a positive electrode 4 including a positive electrode current collector and a positive electrode material mixture layer containing a positive electrode active material and a binder and provided on the positive electrode current collector; a negative electrode 5; a porous insulating layer 6 interposed between the positive electrode 4 and the negative electrode 5; and a nonaqueous electrolyte. The positive electrode 4 has a tensile extension percentage of 3.0% or more. The binder is made of copolymer containing vinylidene fluoride and hexafluoropropylene.Type: ApplicationFiled: July 15, 2009Publication date: June 9, 2011Inventors: Yoshiyuki Muraoka, Miho Tanaka, Kazunori Kubota
-
Publication number: 20090203538Abstract: It is intended to provide a method whereby a plural number of antibodies against cell surface antigens are quickly classified and to provide a method whereby antigens of the thus classified antibodies are quickly identified. Further, it is intended to provide a method of promoting the utilization of the useful data obtained by the above methods. Furthermore, it is intended to provide an antibody which is effective in treating or diagnosing cancer.Type: ApplicationFiled: January 9, 2009Publication date: August 13, 2009Applicant: Institute for Antibodies Co., Ltd.Inventors: Atsushi Sugioka, Mototaka Sugiura, Yasushi Akahori, Nobuhiro Hayashi, Akihiko Takasaki, Miwa Morita, Gene Kurosawa, Mariko Sumitomo, Susumu Tsutsumi, Keiko Ogawa, Kazuki Matsuda, Chiho Muramatsu, Noriko Satou, Masachika Azuma, Yoshinori Ukai, Kazuhiro Suzuki, Yoshikazu Kurosawa, Miho Tanaka, Mamoru Shiraishi
-
Patent number: 6825003Abstract: The present invention provides a cyclic lipopeptide acylase which may effectively deacylate the acyl side chain of a cyclic lipopeptide compound, specifically FR901379 Substance or its analog thereof shown by the following general formula [I], and a process for production of a cyclic peptide compound which comprises the use of said acylase.Type: GrantFiled: January 18, 2002Date of Patent: November 30, 2004Assignee: Fujisawa Pharmaceutical Co., Ltd.Inventors: Satoshi Ueda, Miho Tanaka, Masami Ezaki, Kazutoshi Sakamoto, Seiji Hashimoto, Nobutaka Oohata, Masaru Tsuboi, Michio Yamashita
-
Patent number: 6573084Abstract: There is provided a cyclic lipopeptide acylase which is capable of deacylating the acyl side chain of a cyclic lipopeptide compound, e.g. Substance FR901379 or its analog, of the following general formula [I] with effectiveness as well a method of producing a cyclic peptide compound which comprises using the acylase. [wherein R1 is acyl; R2 is hydroxy or acyloxy; R3 is hydrogen or hydroxy; R4 is hydrogen or hydroxy; R5 is hydrogen or hydroxysulfonyloxy; and R6 is hydrogen or carbamoyl.Type: GrantFiled: September 6, 2000Date of Patent: June 3, 2003Assignee: Fujisawa Pharmaceutical Co., Ltd.Inventors: Satoshi Ueda, Miho Tanaka, Masami Ezaki, Kazutoshi Sakamoto, Seiji Hashimoto, Nobutaka Oohata, Masaru Tsuboi, Michio Yamashita
-
Patent number: 6537789Abstract: There is provided a cyclic lipopeptide acylase which is capable of deacylating the acyl side chain of a cyclic lipopeptide compound, e.g. Substance FR901379 or its analog, of the following general formula [I] with effectiveness as well a method of producing a cyclic peptide compound which comprises using the acylase. [wherein R1 is acyl; R2 is hydroxy or acyloxy; R3 is hydrogen or hydroxy; R4 is hydrogen or hydroxy; R5 is hydrogen or hydroxysulfonyloxy; and R6 is hydrogen or carbamoyl.Type: GrantFiled: September 6, 2000Date of Patent: March 25, 2003Assignee: Fujisawa Pharmaceutical Co., Ltd.Inventors: Satoshi Ueda, Miho Tanaka, Masami Ezaki, Kazutoshi Sakamoto, Seiji Hashimoto, Nobutaka Oohata, Masaru Tsuboi, Michio Yamashita
-
Publication number: 20020115133Abstract: The present invention provides a cyclic lipopeptide acylase which may effectively deacylate the acyl side chain of a cyclic lipopeptide compound, specifically FR901379 Substance or its analog thereof shown by the following general formula [I], and a process for production of a cyclic peptide compound which comprises the use of said acylase.Type: ApplicationFiled: January 18, 2002Publication date: August 22, 2002Applicant: Fujisawa Pharmaceutical Co. Ltd.Inventors: Satoshi Ueda, Miho Tanaka, Masami Ezaki, Kazutoshi Sakamoto, Seiji Hashimoto, Nobutaka Oohata, Masaru Tsuboi, Michio Yamashita
-
Patent number: 6372474Abstract: The present invention provides a cyclic lipopeptide acrylase which may effectively deacylate the acyl side chain of a cyclic lipopeptide compound, specifically FR901379 Substance or its analog thereof shown by the following general formula [I], and a process for production of a cyclic peptide compound which comprises the use of said acylase.Type: GrantFiled: September 12, 2000Date of Patent: April 16, 2002Assignee: Fujisawa Pharmaceutical Co., Ltd.Inventors: Satoshi Ueda, Miho Tanaka, Masami Ezaki, Kazutoshi Sakamoto, Seiji Hashimoto, Nobutaka Oohata, Masaru Tsuboi, Michio Yamashita
-
Patent number: 6207434Abstract: There is provided a cyclic lipopeptide acylase which is capable of deacylating the acyl side chain of a cyclic lipopeptide compound, e.g. Substance FR901379 or its analog, of the general formula [I] with effectiveness as well a method of producing a cyclic peptide compound which comprises using the acylase.Type: GrantFiled: September 3, 1998Date of Patent: March 27, 2001Assignee: Fujisawa Pharmaceutical Co., Ltd.Inventors: Satoshi Ueda, Miho Tanaka, Masami Ezaki, Kazutoshi Sakamoto, Seiji Hashimoto, Nobutaka Oohata, Masaru Tsuboi, Michio Yamashita
-
Patent number: 6146872Abstract: The present invention provides a cyclic lipopeptide acylase which may effectively deacylate the acyl side chain of a cyclic lipopeptide compound, specifically FR901379 Substance or its analog thereof shown by the following general formula [I], and a process for production of a cyclic peptide compound which comprises the use of said acylase.Type: GrantFiled: December 31, 1998Date of Patent: November 14, 2000Assignee: Fukisawa Pharmaceutical Co., Ltd.Inventors: Satoshi Ueda, Miho Tanaka, Masami Ezaki, Kazutoshi Sakamoto, Seiji Hashimoto, Nobutaka Oohata, Masaru Tsuboi, Michio Yamashita
-
Patent number: 6106867Abstract: A propolis food product that contains propolis active ingredients with improved bio-absorbability and is readily ingested. The propolis food products containing propolis extracts are gelled by gelatinizers. The gelantinizers are materials such as shiitake extracts, curdlan, agarics extracts and further including sulfated saccharides, .beta.-glucans, carrageenan, locust bean gum, xanthan gum, or agar. The propolis food products are prepared by water or alcohol extraction. Furthermore, the steps involve preparing a gelantinizer solution by adding a gelatinizer to water and adding propolis extracts thereto so that the amount of the propolis extracts in the food product is from 2 to 25 w/w %, a gel composition is then formed by admixing the solution in order to uniformly disperse the propolis extracts.Type: GrantFiled: April 28, 1999Date of Patent: August 22, 2000Assignee: API Co., Ltd.Inventors: Satoshi Mishima, Miho Tanaka